Development and validation of a method using instrumental planar chromatography for quantitative analysis of carbamazepine in saliva

Journal of the Chilean Chemical Society

Volumn 48, Issue 3, 2003, Pages 71-73

  Mennickent, Sigrid ^a   Vega, Mario ^a   Godoy, Carmen Gloria ^a  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

Author keywords

Analytical parameters; Carbamazepine; Drugs; Epilepsy; HPTLC (high performance thin layer chromatography or instrumental thin layer chromatography or instrumental planar chromatography); Quantitative analysis; Saliva

Indexed keywords

CARBAMAZEPINE;

ACCURACY; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG SALIVA LEVEL; HUMAN; PLANAR CHROMATOGRAPHY; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS; REPRODUCIBILITY; SALIVA ANALYSIS; VALIDATION PROCESS;

EID: 1842638287     PISSN: 07179324     EISSN: None     Source Type: Journal    
DOI: 10.4067/s0717-97072003000300014     Document Type: Article

References (25)

1. W. Garnett, Pharmacotherapy. 20, 191S-199S (2000)
2. J. Hardman, L. Lee. Goodman/Gilman, Las bases farmacológicas de la terapéutica, Mc Graw Hill Interamericana, México (1996)
3. J. Gorrel, U.S. Pharmacist. 75-84 (2002)
4. J. Delgado, W. Remers. Wilson/Gisvolds, Textbook of organic medicinal and pharmaceutical chemistry, Lippincott-Reaven, Philadelphia (1998)
5. N. Ryan et al, J. Am. Acad. Child Adolesc. Psychiatry. 38, 529-536 (1999)
6. C. Page et al. Farmacología Integrada, Harcout, Madrid (1999)
7. Drug Evaluations Annual 1995, American Medical Association, USA (1995)
8. S. Pichini et al, Clin. Pharmacokinet. 30, 211-228 (1996)
9. D. Malamud, BMJ. 305, 207 (1992)
10. M. Lifhitz, Z. Ben-Zui, R. Gorodischer, Ther. Drug Monit. 12, 334-338 (1990)
11. G.W. Rylance and T.A. Moreland, Archives of Disease in Chilhood.56, 637-640 (1981)
12. I. Wilson, Ther. Drug Monit. 18, 482-492 (1996)
13. The United States Pharmacopeia/The National Formulary (USP 25/NF 20), United States Pharmacopeial Convection Inc, USA (2002)
14. J. Chromatography. 93, 238-242 (1974)
15. O. Quattrochi, S. Abelaira, R. Laba. Introducción a la HPLC. Aplicación y Práctica, Ed. Artes Gráficas Farro S.A, Buenos Aires (1992)
16. W. Daniel. Bioestadística, Base para el análisis de las ciencias de la salud, Uteha Noriega Editores, México (1996)
17. P.I. Tomlin, I. McKinlay and I. Smith, Development Medicine/Child Neurology. 28 (6), 713-718 (1986)
18. S. Pichini, I. Altieri, P. Zuccaro and R. Pacifici, Clin. Pharmacokinetic. 30 (3), 211-228 (1996)
19. N. A. Klitgaard and O. Kristensen, Eur. J. Cli. Pharmacol. 31, 91-94 (1986)
20. T. Ohkubo, M. Suno, M. Kudo, T. Uno and K. Sugawara, Ther. Drug Monit. 18(5), 598-603 (1996)
21. J. H. H. Thijssen, C. C. Gispen-De Wied, G. M. van Heeswijk and W. Veeman, Clinical Chemistry. 42(8), 1238-1242 (1996)
22. J. H. Rojas, I. Riberos, M. Martínez and C. Troncoso, Libro de Resúmenes IX Congreso Latinoamericano de Cromatografía y Técnicas Afines, 79-80 (2002)
23. M. Lifshitz, Z. Ben-Zvi and R. Gorodischer, Ther. Drug Monit. 12, 334-338 (1990)
24. th Internacional Conference on Alcohol, Drugs and Traffic Safety. 1, 62 (1995)
25. G.A. Starmer, D.J. Mascord, B. Tattam and R. Zeleny, Report CR141, Federal Office of Road Safety (1994)